{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:55:00Z","timestamp":1788886500480,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"dsm-firmenich AG"},{"DOI":"10.13039\/501100006447","name":"University of Zurich","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006447","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00198-025-07456-7","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T15:05:12Z","timestamp":1744211112000},"page":"1007-1018","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effect of calcifediol and cholecalciferol on muscle function in postmenopausal women: a randomized controlled trial"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4554-658X","authenticated-orcid":false,"given":"Heike A.","family":"Bischoff-Ferrari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bess","family":"Dawson-Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Orav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Ceglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Egli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Kistler-Fischbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Wieczorek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"de Godoi Rezende Costa Molino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"key":"7456_CR1","doi-asserted-by":"crossref","unstructured":"Cashman KD (2022) Global differences in vitamin D status and dietary intake: a review of the data. Endocr Connect 11(1):e210282","DOI":"10.1530\/EC-21-0282"},{"issue":"4","key":"7456_CR2","doi-asserted-by":"publisher","first-page":"P23","DOI":"10.1530\/EJE-18-0736","volume":"180","author":"P Lips","year":"2019","unstructured":"Lips P et al (2019) Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency: a position statement of the European Calcified Tissue Society. Eur J Endocrinol 180(4):P23-p54","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"7456_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1185\/030079908X253429","volume":"24","author":"SK Lim","year":"2008","unstructured":"Lim SK et al (2008) Vitamin D inadequacy in postmenopausal women in Eastern Asia. Curr Med Res Opin 24(1):99\u2013106","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"7456_CR4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/sj.ejcn.1602108","volume":"59","author":"R Andersen","year":"2005","unstructured":"Andersen R et al (2005) Teenage girls and elderly women living in northern Europe have low winter vitamin D status. Eur J Clin Nutr 59(4):533\u2013541","journal-title":"Eur J Clin Nutr"},{"key":"7456_CR5","doi-asserted-by":"publisher","first-page":"e066452","DOI":"10.1136\/bmj-2021-066452","volume":"376","author":"J Hahn","year":"2022","unstructured":"Hahn J et al (2022) Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. BMJ 376:e066452","journal-title":"BMJ"},{"key":"7456_CR6","doi-asserted-by":"crossref","unstructured":"Avenell A, Mak JCS, O'Connell DL (2014) Vitamin D and vitamin D analogues for preventing fractures in post\u2010menopausal women and older men. Cochr Database Syst Rev 2014(4):CD000227","DOI":"10.1002\/14651858.CD000227.pub4"},{"issue":"8","key":"7456_CR7","doi-asserted-by":"publisher","first-page":"E1283","DOI":"10.1210\/jc.2013-1195","volume":"98","author":"R Bouillon","year":"2013","unstructured":"Bouillon R et al (2013) Optimal vitamin D status: a critical analysis on the basis of evidence-based medicine. J Clin Endocrinol Metab 98(8):E1283\u2013E1304","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"7456_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11154-011-9200-6","volume":"13","author":"HA Bischoff-Ferrari","year":"2012","unstructured":"Bischoff-Ferrari HA (2012) Relevance of vitamin D in muscle health. Rev Endocr Metab Disord 13(1):71\u201377","journal-title":"Rev Endocr Metab Disord"},{"issue":"3","key":"7456_CR9","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/jcsm.12547","volume":"11","author":"S Sipil\u00e4","year":"2020","unstructured":"Sipil\u00e4 S et al (2020) Muscle and bone mass in middle-aged women: role of menopausal status and physical activity. J Cachexia Sarcopenia Muscle 11(3):698\u2013709","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"12","key":"7456_CR10","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1097\/GME.0000000000001137","volume":"25","author":"D Bondarev","year":"2018","unstructured":"Bondarev D et al (2018) Physical performance in relation to menopause status and physical activity. Menopause 25(12):1432\u20131441","journal-title":"Menopause"},{"issue":"9","key":"7456_CR11","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1002\/jbmr.4412","volume":"36","author":"LS Bislev","year":"2021","unstructured":"Bislev LS, Grove-Laugesen D, Rejnmark L (2021) Vitamin D and muscle health: a systematic review and meta-analysis of randomized placebo-controlled trials. J Bone Miner Res 36(9):1651\u20131660","journal-title":"J Bone Miner Res"},{"issue":"9","key":"7456_CR12","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.3390\/nu14091860","volume":"14","author":"M Barbagallo","year":"2022","unstructured":"Barbagallo M et al (2022) Effect of calcifediol on physical performance and muscle strength parameters: a systematic review and meta-analysis. Nutrients 14(9):1860","journal-title":"Nutrients"},{"issue":"2","key":"7456_CR13","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3390\/nu13020380","volume":"13","author":"A Corrado","year":"2021","unstructured":"Corrado A et al (2021) Effects of different vitamin D supplementation schemes in post-menopausal women: a monocentric open-label randomized study. Nutrients 13(2):380","journal-title":"Nutrients"},{"issue":"3","key":"7456_CR14","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1007\/s12325-017-0492-0","volume":"34","author":"G Iolascon","year":"2017","unstructured":"Iolascon G et al (2017) Effectiveness of calcifediol in improving muscle function in post-menopausal women: a prospective cohort study. Adv Ther 34(3):744\u2013752","journal-title":"Adv Ther"},{"issue":"1","key":"7456_CR15","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/jbmr.551","volume":"27","author":"HA Bischoff-Ferrari","year":"2012","unstructured":"Bischoff-Ferrari HA et al (2012) Oral supplementation with 25(OH)D3 versus vitamin D3: effects on 25(OH)D levels, lower extremity function, blood pressure, and markers of innate immunity. J Bone Miner Res 27(1):160\u2013169","journal-title":"J Bone Miner Res"},{"issue":"1","key":"7456_CR16","doi-asserted-by":"publisher","first-page":"101435","DOI":"10.1016\/j.jocd.2023.101435","volume":"27","author":"C Shuhart","year":"2024","unstructured":"Shuhart C et al (2024) Executive summary of the 2023 adult position development conference of the international society for clinical densitometry: DXA reporting, follow-up BMD testing and trabecular bone score application and reporting. J Clin Densitom 27(1):101435","journal-title":"J Clin Densitom"},{"key":"7456_CR17","unstructured":"Osteoporose - Pr\u00e4vention D, Behandlung. SVGO\/ASCO Empfehlungen 2015. Available from: https:\/\/www.svgo.ch\/userfiles\/downloads\/SVGO%20Empfehlungen%202015.pdf (accessed 25\/09\/2024)"},{"key":"7456_CR18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bone.2013.10.014","volume":"59","author":"A Jetter","year":"2014","unstructured":"Jetter A et al (2014) Pharmacokinetics of oral vitamin D(3) and calcifediol. Bone 59:14\u201319","journal-title":"Bone"},{"issue":"1","key":"7456_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1210\/jc.2010-2704","volume":"96","author":"AC Ross","year":"2011","unstructured":"Ross AC et al (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96(1):53\u201358","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"7456_CR20","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00198-009-1119-3","volume":"21","author":"HA Bischoff-Ferrari","year":"2010","unstructured":"Bischoff-Ferrari HA et al (2010) Benefit-risk assessment of vitamin D supplementation. Osteoporos Int 21(7):1121\u20131132","journal-title":"Osteoporos Int"},{"issue":"4","key":"7456_CR21","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS et al (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53(4):695\u2013699","journal-title":"J Am Geriatr Soc"},{"key":"7456_CR22","doi-asserted-by":"crossref","unstructured":"EuroQol Group (1990) EuroQol--a new facility for the measurement of health-related quality of life. Health Policy 16(3):199\u2013208","DOI":"10.1016\/0168-8510(90)90421-9"},{"issue":"4","key":"7456_CR23","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1007\/s00394-023-03103-1","volume":"62","author":"E Jodar","year":"2023","unstructured":"Jodar E et al (2023) Calcifediol: a review of its pharmacological characteristics and clinical use in correcting vitamin D deficiency. Eur J Nutr 62(4):1579\u20131597","journal-title":"Eur J Nutr"},{"issue":"5","key":"7456_CR24","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/jn\/nxy024","volume":"148","author":"AMM Vaes","year":"2018","unstructured":"Vaes AMM et al (2018) Cholecalciferol or 25-hydroxycholecalciferol supplementation does not affect muscle strength and physical performance in prefrail and frail older adults. J Nutr 148(5):712\u2013720","journal-title":"J Nutr"},{"issue":"8","key":"7456_CR25","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s00198-018-4520-y","volume":"29","author":"JM Quesada-Gomez","year":"2018","unstructured":"Quesada-Gomez JM, Bouillon R (2018) Is calcifediol better than cholecalciferol for vitamin D supplementation? Osteoporos Int 29(8):1697\u20131711","journal-title":"Osteoporos Int"},{"key":"7456_CR26","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.gene.2018.08.056","volume":"678","author":"L Duan","year":"2018","unstructured":"Duan L et al (2018) Effects of CYP2R1 gene variants on vitamin D levels and status: a systematic review and meta-analysis. Gene 678:361\u2013369","journal-title":"Gene"},{"issue":"12","key":"7456_CR27","doi-asserted-by":"publisher","first-page":"e10575","DOI":"10.1002\/jbm4.10575","volume":"5","author":"CM Girgis","year":"2021","unstructured":"Girgis CM, Brennan-Speranza TC (2021) Vitamin D and skeletal muscle: current concepts from preclinical studies. JBMR Plus 5(12):e10575","journal-title":"JBMR Plus"},{"issue":"3","key":"7456_CR28","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1210\/clinem\/dgaa048","volume":"105","author":"D Shoback","year":"2020","unstructured":"Shoback D et al (2020) Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society Guideline update. J Clin Endocrinol Metab 105(3):587\u2013594","journal-title":"J Clin Endocrinol Metab"},{"key":"7456_CR29","unstructured":"SIGN, SIGN 142 - Management of osteoporosis and the prevention of fragility fractures. 2021, Edinburgh: Scottish Intercollegiate Guidelines Network"},{"issue":"1","key":"7456_CR30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/jcpt.13056","volume":"45","author":"L Lu","year":"2020","unstructured":"Lu L et al (2020) Potential risks of rare serious adverse effects related to long-term use of bisphosphonates: an overview of systematic reviews. J Clin Pharm Ther 45(1):45\u201351","journal-title":"J Clin Pharm Ther"},{"issue":"3","key":"7456_CR31","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/fampra\/cmu088","volume":"32","author":"S Lee","year":"2015","unstructured":"Lee S et al (2015) Increased risk for atypical fractures associated with bisphosphonate use. Fam Pract 32(3):276\u2013281","journal-title":"Fam Pract"},{"issue":"8","key":"7456_CR32","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/jbmr.1893","volume":"28","author":"L Gedmintas","year":"2013","unstructured":"Gedmintas L, Solomon DH, Kim SC (2013) Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta-analysis. J Bone Miner Res 28(8):1729\u20131737","journal-title":"J Bone Miner Res"},{"issue":"4","key":"7456_CR33","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00198-014-3007-8","volume":"26","author":"H Molvik","year":"2015","unstructured":"Molvik H, Khan W (2015) Bisphosphonates and their influence on fracture healing: a systematic review. Osteoporos Int 26(4):1251\u20131260","journal-title":"Osteoporos Int"},{"issue":"5","key":"7456_CR34","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1308\/003588415X14181254789321","volume":"97","author":"B Yue","year":"2015","unstructured":"Yue B et al (2015) Delayed healing of lower limb fractures with bisphosphonate therapy. Ann R Coll Surg Engl 97(5):333\u2013338","journal-title":"Ann R Coll Surg Engl"},{"issue":"3","key":"7456_CR35","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s00198-013-2575-3","volume":"25","author":"SH Lee","year":"2014","unstructured":"Lee SH et al (2014) Risk of osteonecrosis in patients taking bisphosphonates for prevention of osteoporosis: a systematic review and meta-analysis. Osteoporos Int 25(3):1131\u20131139","journal-title":"Osteoporos Int"},{"issue":"2","key":"7456_CR36","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/jbmr.4472","volume":"37","author":"J Everts-Graber","year":"2022","unstructured":"Everts-Graber J et al (2022) Risk of osteonecrosis of the jaw under denosumab compared to bisphosphonates in patients with osteoporosis. J Bone Miner Res 37(2):340\u2013348","journal-title":"J Bone Miner Res"},{"issue":"2","key":"7456_CR37","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/jcsm.12373","volume":"10","author":"R Ram\u00edrez-V\u00e9lez","year":"2019","unstructured":"Ram\u00edrez-V\u00e9lez R et al (2019) Reference values for handgrip strength and their association with intrinsic capacity domains among older adults. J Cachexia Sarcopenia Muscle 10(2):278\u2013286","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"7","key":"7456_CR38","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1007\/s12603-018-1058-9","volume":"22","author":"DM Mijnarends","year":"2018","unstructured":"Mijnarends DM et al (2018) Muscle, health and costs: a glance at their relationship. J Nutr Health Aging 22(7):766\u2013773","journal-title":"J Nutr Health Aging"},{"issue":"1","key":"7456_CR39","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12877-019-1142-y","volume":"19","author":"K Franzon","year":"2019","unstructured":"Franzon K et al (2019) The impact of muscle function, muscle mass and sarcopenia on independent ageing in very old Swedish men. BMC Geriatr 19(1):153","journal-title":"BMC Geriatr"},{"issue":"3","key":"7456_CR40","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s41999-022-00627-3","volume":"13","author":"N Veronese","year":"2022","unstructured":"Veronese N et al (2022) Sarcopenia reduces quality of life in the long-term: longitudinal analyses from the English longitudinal study of ageing. European Geriatric Medicine 13(3):633\u2013639","journal-title":"European Geriatric Medicine"},{"issue":"9","key":"7456_CR41","doi-asserted-by":"publisher","first-page":"e3363","DOI":"10.1210\/clinem\/dgaa414","volume":"105","author":"D Alajlouni","year":"2020","unstructured":"Alajlouni D et al (2020) Decline in muscle strength and performance predicts fracture risk in elderly women and men. J Clin Endocrinol Metab 105(9):e3363\u2013e3373","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"7456_CR42","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00223-018-0478-1","volume":"104","author":"R Pinedo-Villanueva","year":"2019","unstructured":"Pinedo-Villanueva R et al (2019) Health care costs associated with muscle weakness: a UK population-based estimate. Calcif Tissue Int 104(2):137\u2013144","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"7456_CR43","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1249\/MSS.0000000000001448","volume":"50","author":"R Li","year":"2018","unstructured":"Li R et al (2018) Associations of muscle mass and strength with all-cause mortality among US older adults. Med Sci Sports Exerc 50(3):458\u2013467","journal-title":"Med Sci Sports Exerc"},{"issue":"9","key":"7456_CR44","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/aps.2015.55","volume":"36","author":"LH Gao","year":"2015","unstructured":"Gao LH et al (2015) Physical performance and life quality in postmenopausal women supplemented with vitamin D: a two-year prospective study. Acta Pharmacol Sin 36(9):1065\u20131073","journal-title":"Acta Pharmacol Sin"},{"issue":"9","key":"7456_CR45","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1007\/s40520-020-01779-7","volume":"33","author":"S Gonnelli","year":"2021","unstructured":"Gonnelli S et al (2021) Pharmacokinetic profile and effect on bone markers and muscle strength of two daily dosage regimens of calcifediol in osteopenic\/osteoporotic postmenopausal women. Aging Clin Exp Res 33(9):2539\u20132547","journal-title":"Aging Clin Exp Res"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-025-07456-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-025-07456-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-025-07456-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T03:25:51Z","timestamp":1748489151000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-025-07456-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["7456"],"URL":"https:\/\/doi.org\/10.1007\/s00198-025-07456-7","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"30 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Heike A. Bischoff-Ferrari reports grants from the European Commission (grant agreement no. 278588), the University of Zurich, NESTEC, Pfizer Consumer Healthcare, Streuli Pharma, plus non-financial support from dsm-firmenich AG, and Roche Diagnostics. Furthermore, Heike\u00a0A.\u00a0Bischoff-Ferrari\u00a0reports speaker fees from Wild, Pfizer, Vifor, Mylan, Roche Diagnostics, and independent and investigator-initiated grants from Pfizer and from Vifor, outside the submitted work.Bess Dawson-Hughes reports no conflict of interest.E. John Orav reports no conflict of interest.Lisa Ceglia reports no conflict of interest.Melanie Kistler-Fischbacher reports no conflict of interest.Maud Wieczorek reports no conflict of interest.Andreas Egli reports no conflict of interest.Caroline de Godoi Rezende Costa Molino reports no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}